{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:49:03Z","timestamp":1760014143504,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jpba.2023.115601","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T19:38:02Z","timestamp":1690227482000},"page":"115601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS method for simultaneous determination of EVT201 and its five metabolites in human plasma: Application to a clinical study in Chinese healthy subjects"],"prefix":"10.1016","volume":"235","author":[{"given":"Xinrui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-0985","authenticated-orcid":false,"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpba.2023.115601_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3810\/pgm.2014.09.2802","article-title":"Integrating modern concepts of insomnia and its contemporary treatment into primary care","volume":"126","author":"Doghramji","year":"2014","journal-title":"Postgrad. Med."},{"issue":"2","key":"10.1016\/j.jpba.2023.115601_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.mcna.2014.11.013","article-title":"Sleep problems in the elderly","volume":"99","author":"Rodriguez","year":"2015","journal-title":"Med. Clin. N. Am."},{"issue":"6","key":"10.1016\/j.jpba.2023.115601_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann","year":"2017","journal-title":"J. Sleep. Res"},{"issue":"4","key":"10.1016\/j.jpba.2023.115601_bib4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","article-title":"Insomnia pharmacotherapy","volume":"9","author":"Roehrs","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.jpba.2023.115601_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"11","key":"10.1016\/j.jpba.2023.115601_bib6","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.mayocp.2016.07.024","article-title":"Benzodiazepine use in older adults: dangers, management, and alternative therapies","volume":"91","author":"Markota","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jpba.2023.115601_bib7","article-title":"EVT 201: A high affinity, partial positive allosteric modulator of GABA(A) a receptors with preference for the A1-subtype","volume":"31","author":"Kemp","year":"2008","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.jpba.2023.115601_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.sleep.2009.07.012","article-title":"Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness","volume":"11","author":"Walsh","year":"2010","journal-title":"Sleep. Med"},{"key":"10.1016\/j.jpba.2023.115601_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114737","article-title":"Untargeted metabolomic study of acute exacerbation of pediatric asthma via HPLC-Q-Orbitrap-MS","volume":"215","author":"Li","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115601_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114461","article-title":"Targeting tryptophan metabolism reveals Clematichinenoside AR alleviates triptolide-induced hepatotoxicity","volume":"208","author":"Wang","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115601_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpba.2016.04.033","article-title":"Isotope-coded ESI-enhancing derivatization reagents for differential analysis, quantification and profiling of metabolites in biological samples by LC\/MS: a review","volume":"130","author":"Higashi","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.jpba.2023.115601_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/17425255.2018.1519546","article-title":"Drug metabolism and metabolite safety assessment in drug discovery and development","volume":"14","author":"He","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2023.115601_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115122","article-title":"Comprehensive investigation on the metabolism of emodin both in vivo and in vitro","volume":"223","author":"Zhou","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115601_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114107","article-title":"Characterization of phase I and phase II metabolites of hop (Humulus lupulus L.) bitter acids: in vitro and in vivo metabolic profiling by UHPLC-Q-Orbitrap","volume":"201","author":"Salviati","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115601_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jpba.2018.06.001","article-title":"Simultaneous quantification of EVT201, a novel partial positive allosteric GABA(A) receptor modulator, and its two metabolites in human plasma by UHPLC\/MS\/MS","volume":"159","author":"Zhang","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115601_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123723","article-title":"Development and validation of LC-MS\/MS methods for the determination of EVT201 and its five metabolites in human urine: application to a mass balance study","volume":"1223","author":"Liu","year":"2023","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.jpba.2023.115601_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40543-020-00222-w","article-title":"Accurate quantification of EVT201 and its two metabolites in human urine using UHPLC-MS\/MS method with solid phase extraction","volume":"11","author":"Zhou","year":"2020","journal-title":"J. Anal. Sci. Technol."},{"key":"10.1016\/j.jpba.2023.115601_bib18","unstructured":"Food and Drug Administration (FDA), Safety Testing of Drug Metabolites. 2020. \u3008https:\/\/www.fda.gov\/media\/72279\/download\u3009."},{"key":"10.1016\/j.jpba.2023.115601_bib19","unstructured":"Food and Drug Administration\uff08FDA\uff09, Bioanalytical Method Validation Guidance for Industry. 2018. \u3008https:\/\/www.fda.gov\/media\/70858\/download\u3009."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:29:00Z","timestamp":1760002140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":19,"alternative-id":["S0731708523003709"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115601","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS method for simultaneous determination of EVT201 and its five metabolites in human plasma: Application to a clinical study in Chinese healthy subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115601"}}